Skip to main content
Top
Published in: BMC Infectious Diseases 1/2024

Open Access 01-12-2024 | Campylobacter | Case Report

Hemophagocytic lymphohistiocytosis and myopericarditis induced by campylobacter: a case report

Authors: Chia Hua Chang, Chih-Chuan Kao

Published in: BMC Infectious Diseases | Issue 1/2024

Login to get access

Abstract

Background

Hemophagocytic lymphohistiocytosis (HLH) is a severe disorder characterized by excessive activation of the immune system, leading to hypercytokinemia and damage to multiple organs. We report a rare case of HLH with myopericarditis caused by Campylobacter infection.

Case presentation

A 28-year-old male patient with a history of hypertension without medicine control presented at the hospital after a four-day fever, decreasing urine amount, rashes on his trunk and limbs, and other symptoms. He was admitted with a provisional diagnosis of atypical infection and allergic skin rash related to diclofenac. However, his condition deteriorated, and he developed shock, tachycardia, chest distress, and bilateral pleural effusion after admission. Further investigations revealed cardiogenic shock related to myopericarditis, and he was transferred to the ICU. In addition, a stool PCR panel subsequently revealed a positive result for Campylobacter. On day 6, he was diagnosed with HLH. Under Clarithromycin and dexamethasone infusion, leukocytosis, anemia and thrombocytopenia with cardiogenic shock status improved. Then, he was later discharged in stable condition.

Conclusions

HLH and myopericarditis caused by Campylobacter are very rare. Early detection of Campylobacter-induced HLH and multiple organ failure, as well as prompt use of antibiotics and immunosuppressants, can be helpful for prognosis.
Appendix
Available only for authorised users
Literature
1.
go back to reference Gharst G, Oyarzabal OA, Hussain SK. Review of current methodologies to isolate and identify Campylobacter spp. from foods. J Microbiol Methods. 2013;95(1):84–92.CrossRefPubMed Gharst G, Oyarzabal OA, Hussain SK. Review of current methodologies to isolate and identify Campylobacter spp. from foods. J Microbiol Methods. 2013;95(1):84–92.CrossRefPubMed
2.
go back to reference Nisar M, Mushtaq MH, Shehzad W, Hussain A, Nasar M, Nagaraja KV, et al. Occurrence of campylobacter in retail meat in lahore, Pakistan. Acta Trop. 2018;185:42–5.CrossRefPubMed Nisar M, Mushtaq MH, Shehzad W, Hussain A, Nasar M, Nagaraja KV, et al. Occurrence of campylobacter in retail meat in lahore, Pakistan. Acta Trop. 2018;185:42–5.CrossRefPubMed
3.
go back to reference Facciolà A, Riso R, Avventuroso E, Visalli G, Delia S, Laganà P. Campylobacter: from microbiology to prevention. J Prev Med Hyg. 2017;58(2):E79.PubMedPubMedCentral Facciolà A, Riso R, Avventuroso E, Visalli G, Delia S, Laganà P. Campylobacter: from microbiology to prevention. J Prev Med Hyg. 2017;58(2):E79.PubMedPubMedCentral
4.
go back to reference Fica A, Seelmann D, Porte L, Eugenin D, Gallardo R. A case of myopericarditis associated to Campylobacter jejuni infection in the southern hemisphere. Braz J Infect Dis. 2012;16(3):294–6.CrossRefPubMed Fica A, Seelmann D, Porte L, Eugenin D, Gallardo R. A case of myopericarditis associated to Campylobacter jejuni infection in the southern hemisphere. Braz J Infect Dis. 2012;16(3):294–6.CrossRefPubMed
5.
go back to reference Stein RA. Campylobacter jejuni and postinfectious autoimmune diseases: a proof of concept in glycobiology. ACS Infect Dis. 2022;8(10):1981–91.CrossRefPubMed Stein RA. Campylobacter jejuni and postinfectious autoimmune diseases: a proof of concept in glycobiology. ACS Infect Dis. 2022;8(10):1981–91.CrossRefPubMed
6.
go back to reference Close encounters of the microbial kind: everything you need to know about common infections. Gastoenteritis due to campylobacter. 2021. p. 439–50. Close encounters of the microbial kind: everything you need to know about common infections. Gastoenteritis due to campylobacter. 2021. p. 439–50.
7.
go back to reference Sahin O, Kassem II, Shen Z, Lin J, Rajashekara G, Zhang Q. Campylobacter in poultry: ecology and potential interventions. Avian Dis. 2015;59(2):185–200.CrossRefPubMed Sahin O, Kassem II, Shen Z, Lin J, Rajashekara G, Zhang Q. Campylobacter in poultry: ecology and potential interventions. Avian Dis. 2015;59(2):185–200.CrossRefPubMed
8.
go back to reference Keithlin J, Sargeant J, Thomas MK, Fazil A. Systematic review and meta-analysis of the proportion of Campylobacter cases that develop chronic sequelae. BMC Public Health. 2014;14(1):1–19.CrossRef Keithlin J, Sargeant J, Thomas MK, Fazil A. Systematic review and meta-analysis of the proportion of Campylobacter cases that develop chronic sequelae. BMC Public Health. 2014;14(1):1–19.CrossRef
9.
10.
go back to reference Dubuc CE, Cáceres VA, Villalba CM, Uriarte ME, Rubio IH, Otano JB. THU0452 secondary hemophagocytic lymphohistiocytosis: a series of 11 patients. literature review. Ann Rheum Dis. 2013;72(Suppl 3):A317. Dubuc CE, Cáceres VA, Villalba CM, Uriarte ME, Rubio IH, Otano JB. THU0452 secondary hemophagocytic lymphohistiocytosis: a series of 11 patients. literature review. Ann Rheum Dis. 2013;72(Suppl 3):A317.
11.
go back to reference Shi FE, Chen MF, Li YJ, Dong GY, Zhu JH. Campylobacter jejuni-associated hemophagocytic lymphohistiocytosis and guillain-barre syndrome: a case report. Front Med. 2022;9:895923.CrossRef Shi FE, Chen MF, Li YJ, Dong GY, Zhu JH. Campylobacter jejuni-associated hemophagocytic lymphohistiocytosis and guillain-barre syndrome: a case report. Front Med. 2022;9:895923.CrossRef
Metadata
Title
Hemophagocytic lymphohistiocytosis and myopericarditis induced by campylobacter: a case report
Authors
Chia Hua Chang
Chih-Chuan Kao
Publication date
01-12-2024
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2024
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-024-09128-z

Other articles of this Issue 1/2024

BMC Infectious Diseases 1/2024 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.